FULLY SUBSCRIBED

Emcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business improvements and revenue growth potential in the global pharmaceutical market, supporting the company's expansion...

Akme Fintrade India's IPO was completely subscribed shortly after opening on Wednesday, fueled by enthusiastic participation from retail and NII investors. The offering concludes on June 21st.

United Cotfab IPO: The category reserved for retail investors was booked over 2 times, followed by other investors at just 30%. About 50% of the offer is reserved for retail investors and the rest 50% for other investors.

The initial public offering of subscription travel firm Ixigo sailed through on the first day on robust retail interest. Details on this and more in today's ETtech Top 5.

Ixigo IPO GMP: Ixigo IPO comprises a fresh equity sale of Rs 120 crore and an offer for sale (OFS) of up to 6.66 crore shares. Under the OFS, SAIF Partners, Peak XV Partners, Aloke Bajpai, Rajnish Kumar, Micromax Informatics, and Placid Holdings wil...

IPO, which includes a fresh share sale of Rs 128 crore and an offer-for-sale of up to 12.2 million shares, closes on May 24. Around 75% of the IPO is reserved for qualified institutional bidders (QIBs), 15% for non-institutional investors, and the r...

The IPO, priced between Rs 258 to Rs 272 per share, will close on Friday. The company had reserved 9.6 million shares for retail investors.

The retail portion of Digit Insurance's IPO was fully subscribed at 1.45pm. The company had reserved 9.6 million shares for retail investors in the issue that opened on Wednesday. The Rs 2,615-crore IPO comprises a fresh issue of Rs 1,125 crore and ...

On the first day of bidding, the initial public offering (IPO) of Indegene Ltd received a steady response, primarily fueled by strong interest from non-institutional investors (NII).

Vodafone Idea FPO: Rajiv Jain's GQG Partners, which had invested nearly Rs 1,350 crore in Vi’s anchor book, continued to invest in the FPO. Additionally, several other foreign institutional investors, such as Capital Group and Fidelity Investments, ...

In the unlisted market, Ramdevbaba Solvent shares are trading with a GMP of Rs 20. This compares with an offer price of Rs 80 apiece. On the other hand, Grill Splendour's shares are currently commanding a GMP of Rs 8 in the unlisted market as agains...

In the unlisted market, Ramdevbaba Solvent shares are trading with a GMP of Rs 20. This compares with an offer price of Rs 80 apiece. Choice Capital Advisors is acting as the lead manager to the issue and Bigshare Services is the registrar.

Bharti Hexacom's IPO is completely an offer-for-sale and has no fresh equity issue. The company's shares were trading with a premium of Rs 40 in the unlisted market ahead of the issue launch.

About 50% of the offer is reserved for qualified institutional buyers, 35% for retail investors and 15% for non-institutional investors.

In the unlisted market, the company's shares are trading with a GMP of Rs 50. This compares with an upper price band of Rs 288 per share.

Mukka Proteins IPO received a healthy response from investors on the first day of bidding, with the issue sailing through within hours of opening. The demand was driven by retail investors, followed by NIIs. Most analysts gave a 'subscribe' recommen...

In the unlisted market, the company's shares are trading with a premium of Rs 10, marginally up from the previous week.

CEO Byju Raveendran said he is taking steps to ensure transparency on the usage of the funds. He also reiterated in his note that a few vested interests are acting against the edtech at a time when it faces a major cash crunch.

Docmode Health Technologies IPO was entirely a fresh issue of up to 8.49 lakh equity shares aggregating up to Rs 6.7 crore. The company has fixed a price band of Rs 79 apiece, and investors can bid for 1,600 shares in one lot.